Records containing: Systemic Lupus Erythematosus
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-04-13Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
-
CLINICAL_TRIALS study record update · 2025-04-04A Phase 1b/2, Double-Blind, Placebo-Controlled, Randomized, Parallel-Arm Study to Explore the Safety, Pharmacokinetics, and Proof of Biological Activity of DS-7011a in Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-04-02An Open, Single-Arm, Single-Center Clinical Study Assessing the Safety and Efficacy of BCMA-CD19 Targeted Chimeric Antigen Receptor T-Cell Therapy in Multiple Refractory Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2025-03-31Systemic Lupus Erythematosus and Chlordecone Impregnation in Martinique
-
CLINICAL_TRIALS study record update · 2025-03-27Traditional Chinese Five-Tone Therapy As an Adjunctive Treatment for Systemic Lupus Erythematosus: a Prospective Cohort Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-03-26Clinical Study of the Safety and Efficacy of CD19/BCMA CAR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-03-21An Observational Multicenter International Case-control Study for the Assessment of Nailfold Capillary Abnormalities in Patients with Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-03-13A Randomized, Double-Blind, Placebo-Controlled, Phase Ib Study to Evaluate the Safety, Tolerability, And Pharmacokinetics of Gusacitinib in Subjects With Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2025-03-12Assessment of Physician Consideration of Electronic Patient Reported Outcomes, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus Erythematosus, on the Frequency of Therapeutic Adjustments
-
CLINICAL_TRIALS study record update · 2025-03-05A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Trial Evaluating the Efficacy and Safety of TQB3702 Tablets in Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-02-28A Phase I Clinical Study to Evaluate the Safety and Efficacy of ZM001 Injection in the Treatment of Refractory Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-02-28The Prevalence Evaluation of Systemic Lupus Erythematosus in Russian Patients With Reproductive Issues (PRISMA)
-
CLINICAL_TRIALS study record update · 2025-02-20A Phase Ib, Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered CUG252 Following Multiple Dose Administrations in Participants With Mild-to-Moderate SLE
-
CLINICAL_TRIALS study record update · 2025-02-20Phase Ia, Randomized Double-Blinded, Placebo-Controlled Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered CUG252 Following a Single Dose Administration in Normal Health Volunteers.
-
CLINICAL_TRIALS study record update · 2025-02-13A Remotely Delivered CBT Intervention for Youth With cSLE: A Multi-site Patient-engaged Investigation
-
CLINICAL_TRIALS study record update · 2025-02-10A Phase 1b, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Imvotamab in Participants With Severe Systemic Lupus Erythematosus Who Have Failed Standard Therapies
-
CLINICAL_TRIALS study record update · 2025-02-10A Phase 1/2 Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of IMPT-514 in Participants With Active, Refractory Lupus Nephritis and Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-02-04Cohort Follow-up of Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation at the CHRU of Brest
-
CLINICAL_TRIALS study record update · 2025-02-03A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study in Healthy Subjects and Multiple Dose Study of JNJ-55920839 in Subjects With Mild to Moderate Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-01-29Establishing the Salience of Type 1 Interferon Pathway Blockade in the Central Mechanisms of SLE Related Fatigue
-
CLINICAL_TRIALS study record update · 2025-01-28Association of Systemic Immune Inflammatory Index with Disease Activity and Lupus Nephritis in Patients with Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-01-27A Multicenter, Open-label, Single-arm, Multiple-dose Study to Characterize the Pharmacokinetics, Safety and Tolerability of Subcutaneous Ianalumab in Chinese Adult Participants With Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2025-01-24A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study Evaluating the Efficacy and Safety of CM313(SC) Injection in Subjects With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-01-22Addressing Disparities in Lupus Care Through an Integrated Care Management Program (Rheum-iCMP)
-
CLINICAL_TRIALS study record update · 2025-01-20BIRDD: Biomarkers in Inflammatory Rheumatic Diseases Diagnosis - Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus